SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : JNJ-Super company, Super stock!
JNJ 188.87-0.1%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lance Bredvold who wrote (522)2/8/2006 10:17:32 PM
From: epicure  Read Replies (1) of 552
 
upgrade:

yahoo.businessweek.com

and the ADHD problem:

yahoo.reuters.com
"The information was released one day ahead of an FDA advisory panel meeting on how best to study potential risks from the drugs, which include Shire Pharmaceuticals Group Plc's (SHP.L: Quote, Profile, Research) Adderall and Novartis AG's (NVS.N: Quote, Profile, Research) (NOVN.VX: Quote, Profile, Research) Ritalin."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext